Drug Trial Radar · NCT00701363
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects
Last checked: Nov 20, 2026Latest source record: Jan 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
124
Actual
Start
Oct 2008
Primary completion
Mar 2013
Study completion May 2013
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- First posted
- Jun 19, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the efficacy of an extended injection interval schedule of lanreotide Autogel 120 mg in acromegalic subjects who are biochemically controlled on long term treatment with octreotide LAR 10 or 20 mg
Conditions
- Acromegaly
Interventions
Lanreotide Autogel 120 mgDrug
120mg, injections every 6 weeks, then depending on IGF-1 results at Week 24
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Having Maintained Their Injection Interval Schedule of Six Weeks or Increased Their Injection Interval to Eight Weeks Whilst Keeping Their Normalised Insulin Growth Factor (IGF-1) Levels (Age and Sex Adjusted)Time frame: At week 48 (End of Study)
Locations
44 sites in 14 countries. Site status is shown where the registry gives one.
Universidade Federal do Rio de Janeiro - Department of Internal Medicine - Section of Endocrinology - Neuroendocrine Research Center
Rio de Janeiro, Brazil
Hospital das Clínicas de São Paulo - Internal Medicine - Neuroendocrine Unit - Division of Endocrinology and Metabolism
São Paulo, Brazil
Arhus University Hospital - Department of Medicinsk AVd M
Arhus C, Denmark
Righospitalet - University Department of Endocrinology & Internal Medicine P
Copenhagen, Denmark
Odense University Hospital - Department of Endocrinology
Odense C, Denmark
Helsinki University Central Hospital - (HUCH) Division of Endocrinology - Department of Medicine
Helsinki, Finland
Kuopio University Hospital - Department of Medicine, Internal Medicine/Endocrinology and Diabetology Division
Kuopio, Finland
CHU Besançon - Hôpital Jean Minjoz
Besançon, France
Hôpital Avicenne - Bâtiment Madeleine Breis
Bobigny, France
Hôpital Neurologique - Pierre Wertheimer
Bron, France
Hôpital du Bocage Sud - Service d'Endocrinologie
Dijon, France
CH La Rochelle - Hopital Saint Louis - Service de Médecine interne - Endocrinologie - Maladies Métaboliques- Nutrition
La Rochelle, France
Hôpital Du Cluzeau - Service de Médecine B
Limoges, France
Hôpital Archet 1 - Service d'Endocrinologie
Nice, France
CHU de Nîmes - Hôpital Caremeau
Nîmes, France
Hôpital Lariboisière - Service Médecine Interne - Endocrinologie - Nutrition
Paris, France
Hopital Pitié-Salpêtrière - Service d'Endocrinologie
Paris, France
Hôpital Cochin - Saint-Vincent-de-Paul - La-Roche-Guyon
Paris, France
Hôpital Haut Lévêque - Unité de soins normalisés
Pessac, France
Hôpital Robert Debré
Reims, France
Hôpital de Hautepierre, Service de Médecine Interne et Nutrition
Strasbourg, France
CHU de Tours - Hopital Bretonneau - Service Endocrinologie-Diabétologie Medecine B
Tours, France
Evangelismos Hospital - Department of Endocrinology
Athens, Greece
Polykliniki Hospital - Department of Endocrinology
Athens, Greece
Metaxa Hospital - Department of Endocrinology
Piraeus, Greece
B IKA Panagia Hospital - Department of Endocrinology
Thessaloniki, Greece
P. Stradins Clinical University Hospital - Department of Endocrinology
Riga, Latvia
Erasmus Medical Centre - Department of Endocrinology
Rotterdam, Netherlands
UMC Utrecht - Department of Endocrinology, Heidelberglaan 100
Utrecht, Netherlands
Department of Medicine, Haukeland Hospital Jonas Lies
Bergen, Norway
Swietorkryskie Centrum Onkologii, UL. Artwinskiego 3 - Department of endocrinology and Nuclear Medecine
Kielce, Poland
University Hospital in Krakow, Dept. of Endocrinology, Kopernika Str. 17
Krakow, Poland
Samodzielny Publiczny Szpital Kliniczny nr 1, Ul. Pasteura 4
Wroclaw, Poland
University of Medicine and Pharmacy Iuliu Hatieganu
Cluj-Napoca, Romania
Federal State Institution "Endocrinology Research Centre - Federal agency of high-tech medical care" - Neuroendocrinology & Osteopathy Department
Moscow, Russia
I.M. Sechenov Moscow Medical Academy - Endocrinology Department
Moscow, Russia
Clinical Centre of Serbia - Institute for Endocrinology, Diabetes and Metabolic Diseases, - Dr Subotica Street n°13
Belgrade, Serbia
Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Hajduk Veljkova 3-9
Novi Sad, Serbia
Seoul National University hospital, 28 Yongon-dong Chongno-gu
Seoul, South Korea
Yonsei University Severance Hospital - Department of Endocrinology and Metabolism
Seoul, South Korea
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.